This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
Alzheimer's disease is a condition that develops slowly and worsens with time. Alzheimer's disease eventually affects every part of your brain. The condition can affect memory, reasoning, judgement, language, problem-solving, personality, and movement. Preclinical Alzheimer's disease, mild cognitive impairment due to Alzheimer's disease, mild dementia due to Alzheimer's disease, moderate dementia due to Alzheimer's disease, moderate dementia due to Alzheimer's disease, and severe dementia due to Alzheimer's disease are the five stages of Alzheimer's disease. The five stages of Alzheimer's disease will help you comprehend what's happening.
Dementia is a group of disorders that cause memory loss and other mental processes to deteriorate. Dementia is a progressive disease that emerges as a result of physical changes in the brain. It is a condition that becomes worse with time. Dementia progresses rapidly for some people, while it takes years for others to reach an advanced state. Identifying the stage assists doctors in determining the appropriate treatments and facilitates communication between doctors and carers. Mild (or "early"), moderate (or "middle"), and severe (or "late") dementia are the three phases of dementia. However, symptoms are frequently used to designate a more specific stage of dementia.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of